Moderna | MRNA - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Acadia Pharmaceuticals USD 270.57M 450K 2026-09
Agios Pharmaceuticals USD 155.3M 24.53M 2026-06
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
Amgen USD 5.69B 6B 2026-09
Arrowhead Research USD 245.35M 30.35M 2026-06
Biogen USD 2.32B 663.6M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Celltrion KRW 133.99B 14.77B 2026-06
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 62.24M 15.25M 2026-06
Divis Laboratories Ltd INR 22.52B 3.01B 2026-09
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Incyte USD 5.64B 4.67B 2026-09
Ionis Pharmaceuticals USD 373M 2.76M 2026-09
Kangmei Pharma CNY 1.22B 130.32M 2026-06
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Moderna USD 1.18B 223M 2026-09
Organigram Holdings CAD 100.45M 30.86M 2026-06
Ovoca Bio EUR 173K 990K 2025-12
Pharma Mar EUR 46.77M 4.24M 2026-09
Puma Biotechnology USD 49.26M 3.2M 2024-06
Qiagen NV USD 393.64M 17.95M 2026-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Sartorius EUR 746.5M 1.3M 2026-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tilray USD 237.52M 17.34M 2025-09
Ultragenyx Pharmaceutical USD 283M 6M 2026-09
United Therapeutics USD 6.28B 124.3M 2026-09
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.54B 90.74M 2026-09